Trends in the treatment of cutaneous T-cell lymphoma – critical evaluation and perspectives on vorinostat
Sophia Rangwala, Madeleine Duvic, Chunlei ZhangDepartment of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USAAbstract: Epigenetic modification with small molecule histone deacetylase inhibitors has been a promising new anti-neoplastic approach for various solid and...
Enregistré dans:
Auteurs principaux: | Zhang CL, Duvic M, Rangwala S |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2012
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/a3c1e6d15fda411cb1a406a59d3ef5d8 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Critical appraisal of belinostat in the management of T-cell lymphoma – patient considerations
par: Bodiford A, et autres
Publié: (2015) -
Reduced intensity treatment in early-stage Hodgkin’s lymphoma
par: Armitage JO, et autres
Publié: (2011) -
mTOR inhibitor in the treatment of Hodgkin’s lymphoma: a case report
par: Provencio M., et autres
Publié: (2011) -
First-line therapy of chronic myeloid leukemia – focus on dasatinib
par: Amrein PC
Publié: (2012) -
Developments in anaplastic large-cell lymphoma: targeting the anaplastic lymphoma kinase
par: Farina F, et autres
Publié: (2014)